High-resolution imaging for skin tumors using advanced optical technology

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a new high-resolution optical coherence tomography (OCT) system for diagnosing pigmented and non-pigmented skin tumors. The ApolloVue® S100 Image System allows non-invasive, real-time imaging of skin lesions at a cellular level, potentially reducing the need for invasive biopsies. By providing detailed cross-sectional and en-face images, this technology aims to enhance the accuracy of skin cancer diagnoses. The study will involve patients with skin lesions that are suspected to be cancerous or benign but require further examination.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients aged \> 18 years
* Willingness to participate in this study including the assessment with high resolution OCT
* Skin lesion/tumor with suspicion for skin cancer that requires skin biopsy or complete excision
* Benign skin tumor that is scheduled for excision due to suspicion, irritation or for cosmetic reason

Exclusion Criteria:

* Patients aged \< 18 years
* Any unstable medical or psychological conditions
* Unwillingness to participate in this study including the assessment with high resolution OCT

Where it's running

• CMB COLLEGIUM MEDICUM BERLIN GmbH
  Berlin, Germany Recruiting

Study contacts

• Principal investigator: Martina Ulrich, MD — CMB COLLEGIUM MEDICUM BERLIN GmbH
• Study coordinator: Emily Tsai, PhD
• Email: emily@mdamo.com
• Phone: 886-2-87523198

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Mobile sun protection support to help young adults stay safe in the sun

  This project tests a mobile health program to see if reminders, education, planning tools, and real-time sun exposure information can help young adults protect their skin from excessive sun exposure.

  Recruiting University of Utah · Salt Lake City, Utah · NCT07830394

• Psycho-physiological profiling of people with low versus high heat resilience

  This project will test whether controlled heat and UV exposures plus physiological and psychological measurements can identify healthy adults who are more or less resilient to heat.

  Recruiting at 2 sites University of Thessaly · Copenhagen and 1 other locations · NCT07510061

• Cosibelimab for tough CSCC in kidney transplant recipients or blood cancers

  This trial tests cosibelimab in people with advanced cutaneous squamous cell carcinoma who have a kidney transplant or certain blood cancers to see if it is safe and helpful for them.

  Recruiting at 2 sites Phase 4 Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT07426484

• First-line immunotherapy and PD-L1 testing for metastatic melanoma in Slovenia

  This study will see if first-line immunotherapy (pembrolizumab, nivolumab, or ipilimumab plus nivolumab) works for adults in Slovenia with metastatic melanoma and whether PD-L1 measurements predict who responds.

  Recruiting Institute of Oncology Ljubljana · Ljubljana · NCT07422779

• Optical and multi-modal analysis to help diagnose skin cancer

  This project tests whether combining optical spectroscopy and imaging data from skin samples can help diagnose skin cancer in people with skin concerns.

  Recruiting Centre Hospitalier Régional Metz-Thionville · Metz · NCT07406022

• Early skin tumor detection with telemedicine in primary care

  This project will test whether a telemedicine tool used by general practitioners can help detect suspicious skin lesions earlier in people with fair skin in the Czech Republic.

  Recruiting at 2 sites Institute of Health Information and Statistics of the Czech Republic · Brno and 4 other locations · NCT07349940

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.